Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin.

PloS One
Jean-Michel GarciaJ S M Peiris

Abstract

It is increasingly clear that influenza A infection induces cross-subtype neutralizing antibodies that may potentially confer protection against zoonotic infections. It is unclear whether this is mediated by antibodies to the neuraminidase (NA) or haemagglutinin (HA). We use pseudoviral particles (H5pp) coated with H5 haemagglutinin but not N1 neuraminidase to address this question. In this study, we investigate whether cross-neutralizing antibodies in persons unexposed to H5N1 is reactive to the H5 haemagglutinin. We measured H5-neutralization antibody titers pre- and post-vaccination using the H5N1 micro-neutralization test (MN) and H5pp tests in subjects given seasonal vaccines and in selected sera from European elderly volunteers in a H5N1 vaccine trial who had detectable pre-vaccination H5N1 MN antibody titers. We found detectable (titer > or = 20) H5N1 neutralizing antibodies in a minority of pre-seasonal vaccine sera and evidence of a serological response to H5N1 in others after seasonal influenza vaccination. There was excellent correlation in the antibody titers between the H5N1 MN and H5pp tests. Similar correlations were found between MN and H5pp in the pre-vaccine sera from the cohort of H5N1 vaccine trial recipient...Continue Reading

References

Apr 1, 1974·The Journal of Infectious Diseases·R B CouchE D Kilbourne
Oct 16, 2004·Expert Review of Anti-infective Therapy·Suzanne L Epstein
Mar 31, 2006·The New England Journal of Medicine·John J TreanorMark Wolff
Jul 1, 1910·The Journal of Physiology·L Hill, M Flack
Dec 21, 2006·Emerging Infectious Diseases·Sirenda VongTouch Sok
Apr 6, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Isabelle NefkensRalf Altmeyer
Jan 18, 2008·The New England Journal of Medicine·UNKNOWN Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian InfTimothy M Uyeki
Apr 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Arun K KashyapRichard A Lerner
Jul 30, 2008·Microbes and Infection·Kristie M GrebeJack R Bennink
Feb 24, 2009·Nature Structural & Molecular Biology·Taia T Wang, Peter Palese
Feb 24, 2009·Nature Structural & Molecular Biology·Jianhua SuiWayne A Marasco
Mar 3, 2009·Science·Damian C EkiertIan A Wilson
Nov 10, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Jean-Michel GarciaJ S Malik Peiris

❮ Previous
Next ❯

Citations

Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jianhua SuiWayne A Marasco
May 21, 2013·The Journal of Infectious Diseases·Maciej F BoniMarion Koopmans
Jun 23, 2012·Science·Maria D Van KerkhoveNeil M Ferguson
Jun 6, 2013·Virus Research·Guus F Rimmelzwaan, Jacqueline M Katz
Apr 21, 2011·Expert Review of Anti-infective Therapy·Jean-Michel Garcia, Jimmy C C Lai
Jan 1, 2014·Vaccines·Claudia Maria TrombettaEmanuele Montomoli
Jun 23, 2015·Expert Review of Vaccines·Barnaby E YoungYee Sin Leo
Apr 2, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Philippe CavaillerPhilippe Buchy
Feb 26, 2015·The Journal of Infectious Diseases·Salah Uddin KhanGregory C Gray
Apr 15, 2017·EBioMedicine·Steven RockmanDarryl Maher

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
IECs

Clinical Trials Mentioned

NCT00415129

Related Concepts